TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 19:58
TG Therapeutics Market Cap : 8.580B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.308B |
| August 20, 2026 | 7.740B |
| August 19, 2026 | 7.913B |
| August 18, 2026 | 7.694B |
| August 17, 2026 | 7.544B |
| August 14, 2026 | 7.461B |
| August 13, 2026 | 7.339B |
| August 12, 2026 | 7.577B |
| August 11, 2026 | 7.639B |
| August 10, 2026 | 7.525B |
| August 07, 2026 | 7.617B |
| August 06, 2026 | 7.585B |
| August 05, 2026 | 7.636B |
| August 04, 2026 | 7.460B |
| August 03, 2026 | 7.068B |
| July 31, 2026 | 7.965B |
| July 30, 2026 | 8.195B |
| July 29, 2026 | 8.187B |
| July 28, 2026 | 8.400B |
| July 27, 2026 | 8.535B |
| July 24, 2026 | 8.579B |
| July 23, 2026 | 8.497B |
| July 22, 2026 | 8.065B |
| July 21, 2026 | 8.259B |
| July 20, 2026 | 8.261B |
| Date | Value |
|---|---|
| July 17, 2026 | 8.400B |
| July 16, 2026 | 8.409B |
| July 15, 2026 | 8.636B |
| July 14, 2026 | 8.403B |
| July 13, 2026 | 8.422B |
| July 10, 2026 | 8.745B |
| July 09, 2026 | 9.042B |
| July 08, 2026 | 8.762B |
| July 07, 2026 | 8.889B |
| July 06, 2026 | 8.492B |
| July 02, 2026 | 8.161B |
| July 01, 2026 | 8.194B |
| June 30, 2026 | 8.411B |
| June 29, 2026 | 8.530B |
| June 26, 2026 | 8.547B |
| June 25, 2026 | 8.210B |
| June 24, 2026 | 8.206B |
| June 23, 2026 | 8.258B |
| June 22, 2026 | 8.328B |
| June 18, 2026 | 8.148B |
| June 17, 2026 | 7.884B |
| June 16, 2026 | 7.737B |
| June 15, 2026 | 7.701B |
| June 12, 2026 | 7.581B |
| June 11, 2026 | 7.356B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 10.12B |
| MAIA Biotechnology, Inc. | 82.41M |
| Vericel Corp. | 2.167B |
| Incyte Corp. | 25.72B |
| Regeneron Pharmaceuticals, Inc. | 85.69B |
Market Cap Related Metrics
| PE Ratio | 20.41 |
| PS Ratio | 11.18 |
| PEG Ratio | 0.0322 |
| Price to Book Value | 14.20 |
| Price to Free Cash Flow | 514.00 |
| Price | 56.05 |
| Earnings Yield | 4.90% |
| PEGY Ratio | 0.0322 |
| Operating PE Ratio | 65.55 |
| Normalized PE Ratio | 20.03 |